论文部分内容阅读
为了准确地选择宫颈浸润癌患者的手术范围 ,对 2 42例浸润癌患者的手术方式进行了探讨 ,其中 a期 19例、 b期 16 2例、 a期 16例、 b1 期 18例、放疗后未控或复发癌共 2 7例。 类手术 4例 ( a1 期 ) , 类手术 5例( a1 期 )、 类手术 10 4例、 类手术 12 5例、 类及 类手术各 2例。随访 5年。结果 : a、 b1 期 5年生存率均为 10 0 % , b2 期 5年生存率为 91.11% , b3期为 86 .11% , a及 b1 期 5年生存率分别为 81.2 5 %及 77.78% ,放疗后未控及复发癌的 5年生存率为 6 2 .2 3%。手术后主要并发症为泌尿道感染 ,膀胱功能障碍及输尿管瘘 ,其发生率随手术范围的扩大而增加。提示 :宫颈浸润癌手术方式的选择 ,应针对每个患者治疗的需要 ,选择一种合适的手术 ,既不盲目扩大手术范围 ,也不无原则缩小手术范围
In order to accurately select the surgical range of patients with invasive cervical cancer, the operation of 42 cases of invasive cancer patients were explored, of which 19 cases of a period, b period of 16 2 cases, a period of 16 cases, b1 18 cases after radiotherapy A total of 27 cases of uncontrolled or recurrent cancer. Four kinds of surgery (a1 stage), five kinds of operation (a1 stage), 104 kinds of operation, 125 kinds of operation and two kinds of operation were performed. Followed up for 5 years. Results: The 5-year survival rates of a and b1 were 100%, the 5-year survival rate of b2 was 91.11% and the b3 was 86.11%. The 5-year survival rates of a and b1 were 81.2 5% and 77.78% The 5-year survival rate of uncontrolled and recurrent cancer after radiotherapy was 62.23%. The main complications after surgery were urinary tract infection, bladder dysfunction and ureteric fistula, the incidence increased with the expansion of the surgical range. Tip: The choice of surgical approach to invasive cervical cancer should be based on the needs of each patient treatment, choose a suitable surgery, neither blindly expand the scope of the operation, or no principle to narrow the scope of the operation